Please be advised We highly recommend that you Read all medication leaflet carefully before you start taking any medicine because it contains important information for you. Rhinex Relief 50 micrograms/actuation Nasal spray, suspension
ACTIVE INGREDIENT: mometasone furoate
Rhinex Relief is used in adults to treat the symptoms of seasonal allergic rhinitis, after a seasonal allergic rhinitis has been diagnosed by a physician.
Adults (including the elderly)
- The usual recommended dose is two sprays (50 micrograms/actuation) in each nostril once daily (total dose 200
micrograms). Once symptoms are controlled, dose reduction to one spray in each nostril (total dose 100
micrograms) may be effective for maintenance.
Rhinex Relief demonstrated a clinically significant onset of action within 12 hours after the first dose in some patients
with seasonal allergic rhinitis; however, full benefit of treatment may not be achieved in the first 48 hours. Therefore,
the patient should continue regular use to achieve full therapeutic benefit.
Treatment with Rhinex Relief may need to be initiated some days before the expected start of the pollen season in
patients who have a history of moderate to severe symptoms of seasonal allergic rhinitis.
If there is no/insufficient improvement of the symptoms after a maximum of 14 days of use, medical advice is required.
Rhinex Relief should not be used continuously for longer than three months without medical advice.
Rhinex Relief should not be used in children and adolescents below the age of 18.